Levetiracetam
Product Images NDC 53808-1042

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 53808-1042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 500mg (500mg Trigen)

Label for LEVETIRACETAM 500 mg tablets. The package contains 30 tablets and is labeled for prescription use only. Manufactured by DOH Central Pharmacy, State of Florida, Tallahassee, FL. The label includes lot number 12301A and expiration date 03/10/2014, along with a UPC barcode.*

FDA Label Image

Chemical Structure (Levetiracetam 01)

Chemical structure of levetiracetam showing its molecular arrangement with a pyrrolidone ring and side chains including ethyl, methyl, and amide groups.*

FDA Label Image

Figure 1 (Levetiracetam 02)

A bar graph comparing the percentage of patients in three groups: placebo (7.4%), levetiracetam 1000 mg/day (37.1%), and levetiracetam 3000 mg/day (39.6%). The x-axis shows treatment groups with sample sizes, and the y-axis shows the percentage of patients from 0% to 45%.*

FDA Label Image

Figure 2 (Levetiracetam 03)

A bar chart comparing the percentage of patients across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). Each group includes the sample size (N) with corresponding values on the vertical axis representing the percentage of patients.*

FDA Label Image

Figure 3 (Levetiracetam 04)

A bar chart comparing the percentage of patients between placebo and Levetiracetam 3000 mg/day groups. The placebo group (N=104) shows 14.4% of patients, while the Levetiracetam group (N=180) shows 39.4%. The y-axis represents the percentage of patients from 0% to 45%.*

FDA Label Image

Figure 4 (Levetiracetam 05)

A bar graph comparing percentage of patients for Placebo and Levetiracetam groups. The Placebo group (N=97) shows approximately 19.6%, while the Levetiracetam group (N=101) shows approximately 44.6%, with an asterisk above the Levetiracetam bar. The y-axis is labeled '% of Patients' ranging from 0% to 45%.*

FDA Label Image

Figure 5 (Levetiracetam 06)

A bar chart comparing the percentage of patients in two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients, ranging from 0% to 100%.*

FDA Label Image

Logo (Levetiracetam 07)

LEVETIRACETAM tablet bottle label showing product name LEVETIRACETAM, with the labeler as State of Florida DOH Central Pharmacy. The label includes standard pharmaceutical information such as lot number, expiration date, fill date, and dosage instructions, and features a white and blue color scheme with a bar code on the side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.